Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

2.8K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
2.8K
Oogenesis02:07

Oogenesis

64.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
64.4K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

492
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
492
Infertility in Females01:28

Infertility in Females

402
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
402
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

700
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
700

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioactive Compound-Integrated Metal Nanoparticles Promote Wound Repair in Diabetic Conditions: Evidence from an Animal Study.

Applied biochemistry and biotechnology·2026
Same author

Selenium nanoparticle production using <i>Azadirachta indica</i> extract: biosynthesis, characterization, and cytotoxic effects in fibroblast cells.

Preparative biochemistry & biotechnology·2026
Same author

Artificial intelligence in oral oncology: Current advances and future potential in diagnosis, prognosis, and therapeutic decision-making.

Cancer treatment and research communications·2026
Same author

Polycystic ovarian syndrome - Exploring the therapeutic and biomedical insights into the role of silver nanoparticles.

The Journal of steroid biochemistry and molecular biology·2026
Same author

Nanoparticle-based oral rinse in prevention of white spot lesions in orthodontic treatment: A systematic review.

Journal of orthodontic science·2025
Same author

Association of CYP27B1 promoter gene variants of vitamin D pathway with pulmonary tuberculosis and vitamin D levels.

Steroids·2025

Related Experiment Video

Updated: Sep 12, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.2K

Inducing agents and PCOS - A comprehensive analysis.

Dhanyaa Muthukumaran1, Jayalakshmi Kumar1, Rajeshkumar Shanmugam1

  • 1Nanobiomedicine Lab, Department of Anatomy, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, TamilNadu 602105, India.

The Journal of Steroid Biochemistry and Molecular Biology
|August 7, 2025
PubMed
Summary

Animal models are crucial for understanding Polycystic Ovary Syndrome (PCOS). This review evaluates agents used to create PCOS models in animals, assessing their ability to mimic human disease symptoms for better research.

Keywords:
Animal modelsDrug administrationInducing agentsPCOS

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.4K

Related Experiment Videos

Last Updated: Sep 12, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.2K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.0K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.4K

Area of Science:

  • Endocrinology
  • Reproductive Biology
  • Animal Modeling

Background:

  • Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder with unclear etiology.
  • Animal models are essential for studying PCOS mechanisms and developing treatments.

Purpose of the Study:

  • To critically evaluate agents used in PCOS animal models.
  • To assess the ability of these models to mimic human PCOS manifestations.
  • To compare the strengths and limitations of different induction agents.

Main Methods:

  • Review of induction agents: androgens, estrogen, aromatase inhibitors, endocrine disruptors, and diet.
  • Analysis of animal species used: rats, mice, zebrafish.
  • Evaluation of clinical, metabolic, and reproductive outcomes in models.

Main Results:

  • Various agents successfully induce PCOS features like hyperandrogenism and anovulation in animal models.
  • Each agent and model exhibits unique strengths and limitations in replicating human PCOS.
  • Models provide insights into specific PCOS aspects but none fully replicate the human syndrome.

Conclusions:

  • Animal models are vital for PCOS research and therapeutic testing.
  • Careful selection of induction agents and species is crucial for translational relevance.
  • Future models should integrate reproductive and metabolic features for improved clinical applicability.